Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 6.522% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) Clc1ccc(NC2=NCCCS2)cc1Cl
b.) Cc1nc(CCNC(=O)Cc2ccccc2)cs1
c.) CC(C)CN(C(=O)c1ccco1)c1nc2ccccc2s1
Answer: b. Cc1nc(CCNC(=O)Cc2ccccc2)cs1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc(CCNC(=O)Cc2ccccc2)cs1
Cc1nc(CCNC(=O)Cc2ccccc2)cs1
N-[2-(2-methyl-1,3-thiazol-4-yl)ethyl]-2-phenylacetamide